Magellan Health Inc (MGLN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Magellan Health Inc (MGLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9904
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Magellan Health Inc (Magellan) is a health care management company which manages behavioral health, radiology and specialty pharmaceuticals, and public sector pharmacy benefits programs. The company provides behavioral healthcare, specialty solutions, and pharmacy management services and integrated physical and behavioral care management for special populations. It caters solutions to its customers including, health plans, insurance companies, corporations, labor unions, various military and governmental agencies, managed care organizations and others. Magellan is headquartered in Scottsdale, Arizona, the US.

Magellan Health Inc (MGLN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Magellan Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Magellan Health Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Magellan Health Services Enters Into Agreement With Rethink Autism To Provide Autism Assist 10
Magellan Health Services Forms Joint Venture With Phoenix Health Plan 11
Acquisition 12
Magellan Health Acquire 4D Pharmacy Management Systems for USD85 Million 12
Magellan Health Acquires 100% Stake in HSM Physical Health 13
Magellan Health Services Acquires CDMI 14
Magellan Health Services Completes Acquisition Of Partners RX, Pharmacy Benefit Management Company, For US$100 Million 15
Magellan Health Inc – Key Competitors 16
Magellan Health Inc – Key Employees 17
Magellan Health Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Recent Developments 20
Financial Announcements 20
Jul 27, 2018: Magellan Health Reports Second Quarter 2018 Financial Results 20
Apr 26, 2018: Magellan Health Reports First Quarter 2018 Financial Results 22
Feb 27, 2018: Magellan Health Reports Fourth Quarter 2017 and Full Year Financial Results 24
Nov 01, 2017: Magellan Health Reports Third Quarter 2017 Financial Results 26
Jul 28, 2017: Magellan Health Reports Second Quarter 2017 Financial Results 28
Apr 26, 2017: Magellan Health Reports First Quarter 2017 Financial Results 30
Feb 24, 2017: Magellan Health Reports Fourth Quarter 2016 and Full Year Financial Results 32
Corporate Communications 34
May 29, 2018: Magellan Health Appoints Swati Abbott And Matthew J. Simas As Board Members 34
Legal and Regulatory 35
Apr 21, 2017: Magellan Management Earns URAC Reaccreditation in Pharmacy Benefit Management 35
Other Significant Developments 36
Oct 12, 2018: Magellan complete care of Arizona now serves AHCCCS medicaid members 36
Mar 01, 2018: Magellan Rx Management’s Annual Medical Pharmacy Trend Report Released 37
Feb 13, 2017: Magellan Complete Care of Virginia Enters into Contract for Commonwealth Coordinated Care Plus Program 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Magellan Health Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Magellan Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Magellan Health Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Magellan Health Services Enters Into Agreement With Rethink Autism To Provide Autism Assist 10
Magellan Health Services Forms Joint Venture With Phoenix Health Plan 11
Magellan Health Acquire 4D Pharmacy Management Systems for USD85 Million 12
Magellan Health Acquires 100% Stake in HSM Physical Health 13
Magellan Health Services Acquires CDMI 14
Magellan Health Services Completes Acquisition Of Partners RX, Pharmacy Benefit Management Company, For US$100 Million 15
Magellan Health Inc, Key Competitors 16
Magellan Health Inc, Key Employees 17
Magellan Health Inc, Subsidiaries 18
Magellan Health Inc, Joint Venture 19

List of Figures
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Magellan Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Magellan Health Inc (MGLN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seegene Inc (096530):企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • SJVN Ltd (SJVN):電力:M&Aディール及び事業提携情報
    Summary SJVN Limited (SJVN), formerly Satluj Jal Vidyut Nigam Limited-SJVNL, generates and sells hydroelectric power in India. It was formed as a joint venture between the Government of India (GOI) and the Government of Himachal Pradesh (GOHP). The company also focuses on the designing, planning, de …
  • Scapa Group plc (SCPA):企業の財務・戦略的SWOT分析
    Scapa Group plc (SCPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • eLong, Inc.:企業の戦略・SWOT・財務情報
    eLong, Inc. - Strategy, SWOT and Corporate Finance Report Summary eLong, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • EnviTec Biogas AG (ETG):企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hydrogenics Corporation (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corporation (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SBI Pharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SBI Pharmaceuticals Co Ltd (SBI Pharma), formerly SBI Alapromo Co Ltd, a subsidiary of SBI Holdings Inc, is a healthcare solution provider that develops and manufactures 5-ALA (5-Aminolevulinic Acid) based products in the areas of medicines for cancer cell identification and cancer diagnosis …
  • Viridian Group Investments Ltd:電力:M&Aディール及び事業提携情報
    Summary Viridian Group Investments Limited (Viridian), a subsidiary of Viridian Group Holdings Limited, is an independent energy company. Through subsidiaries, it generates and supplies electricity in Northern Ireland and the Republic of Ireland (RoI). It supplies natural gas to business customers i …
  • QuickLogic Corporation (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corporation (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ORBCOMM Inc (ORBC):企業の財務・戦略的SWOT分析
    ORBCOMM Inc (ORBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bharat Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Vesteda Group:企業の戦略・SWOT・財務情報
    Vesteda Group - Strategy, SWOT and Corporate Finance Report Summary Vesteda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cullinan Holdings Limited
    Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cullinan Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • MolMed SpA (MLM):企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • FLX Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary FLX Bio Inc (FLX Bio) is an immuno-oncology company that discovers and develops novel immuno-oncology agents. The company develops lead oral small molecule compound, FLX475, blocks a receptor called CCR4, found on nearly all human Treg cells that binds to secreted factors made in the tumor m …
  • Nayara Energy Ltd:企業の戦略的SWOT分析
    Nayara Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • British American Tobacco Bangladesh:企業の戦略・SWOT・財務情報
    British American Tobacco Bangladesh - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco Bangladesh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆